Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Cardiac Complications in Patients With Community-Acquired Pneumonia
2012
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Predictive Value of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab PCR Assay for MRSA Pneumonia
2013
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Beta‐lactam plus macrolides or beta‐lactam alone for community‐acquired pneumonia: A systematic review and meta‐analysis
2016
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Key mechanisms governing resolution of lung inflammation
2016
Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis
2012
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis
2020
Risk Factors Associated with Potentially Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia
2014
Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia
2014
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia
2011
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Risk factors for drug-resistant bacterial pneumonia in older patients hospitalized with pneumonia in a Chinese population
2013
Cardiovascular outcomes associated with use of clarithromycin: population based study
2016
IL-1R and MyD88 Contribute to the Absence of a Bacterial Microbiome on the Healthy Murine Cornea
2018 StandoutNobel
Cystic fibrosis
2016 Standout
Variation in Empiric Coverage Versus Detection of Methicillin-ResistantStaphylococcus aureusandPseudomonas aeruginosain Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers
2017
Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia
2016
Tuberculosis
2015
Antithrombotic Therapy for VTE Disease
2016 Standout
Relationships among initial hospital triage, disease progression and mortality in community‐acquired pneumonia
2012
Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia
2015
Predicting risk of drug-resistant organisms in pneumonia: Moving beyond the HCAP model
2014
Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index
2011
Do no harm: a roadmap for responsible machine learning for health care
2019 Standout
Is the Present Definition of Health Care–Associated Pneumonia the Best Way to Define Risk of Infection with Antibiotic-Resistant Pathogens?
2012
A Generalizable, Data-Driven Approach to Predict Daily Risk ofClostridium difficileInfection at Two Large Academic Health Centers
2018
TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy
2019 Standout
Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia
2015
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Systematic Review of the Literature
2015
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis
2011
The Danish National Patient Registry: a review of content, data quality, and research potential
2015 Standout
Prediction of methicillin-resistant Staphylococcus aureusin patients with non-nosocomial pneumonia
2013
Neutrophil extracellular traps in COVID-19
2020
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
2014
Acute respiratory distress syndrome
2019 Standout
Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case–control study
2017
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
2016
Selection of empirical antibiotics for health care-associated pneumonia via integration of pneumonia severity index and risk factors of drug-resistant pathogens
2015
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Acute pneumonia and the cardiovascular system
2013
Heritability of Respiratory Infection with Pseudomonas aeruginosa in Cystic Fibrosis
2012
Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis
2013
Airway Mucus Function and Dysfunction
2010 Standout
Treatment of Idiopathic Bronchiectasis With Aerosolized Recombinant Human DNase I
1998
How to derive and validate clinical prediction models for use in intensive care medicine
2014
Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio
2017
Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients
2011
Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia
2015
Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006–2010
2015
Lung disease modifier genes in cystic fibrosis
2014
Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study
2014
Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults
2015
The pros, cons, and many unknowns of probiotics
2019 Standout
Health care–associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes
2016
Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection
2018
Identifying Treatments That Halt Progression of Pulmonary Disease in Cystic Fibrosis
1997
Community-Acquired Pneumonia
2014
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation
2013
The Interrelationship of Sputum Inflammatory Markers in Patients with Chronic Bronchitis
1999
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study
2015
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases
2016
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Predictors of P seudomonas and methicillin‐resistant S taphylococcus aureus in hospitalized patients with healthcare‐associated pneumonia
2015
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Clinical review: Early treatment of acute lung injury - paradigm shift toward prevention and treatment prior to respiratory failure
2012
Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score
2016
Laboratory-Confirmed Respiratory Infections as Predictors of Hospital Admission for Myocardial Infarction and Stroke: Time-Series Analysis of English Data for 2004–2015
2018
Healthcare‐associated pneumonia: A US disease or relevant to the A sia P acific, too?
2013
Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis
2017
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
2021 StandoutNobel
Positive predictive value of the ICD-10 hospital diagnosis of pleural empyema in the Danish National Registry of Patients
2011
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
Outcomes of Health Care–Associated Pneumonia Empirically Treated with Guideline-Concordant Regimens Versus Community-Acquired Pneumonia Guideline–Concordant Regimens for Patients Admitted to Acute Care Wards from Home
2013
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Invasive Candidiasis
2015 Standout
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
2014
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
2020 Standout
Development of Liposomal Ciprofloxacin to Treat Lung Infections
2016
Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia
2015
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia
2014
The respiratory threat posed by multidrug resistant G ram‐negative bacteria
2017
The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung
2015
Cystic fibrosis: An update for clinicians. Part 1: Nutrition and gastrointestinal complications
2014
Axial and Reformatted Four-Chamber Right Ventricle–to–Left Ventricle Diameter Ratios on Pulmonary CT Angiography as Predictors of Death After Acute Pulmonary Embolism
2012
The Importance of the Pseudomonas aeruginosa Type III Secretion System in Epithelium Traversal Depends upon Conditions of Host Susceptibility
2015
Duration of Antibiotic Treatment in Community-Acquired Pneumonia
2016
Corneal surface glycosylation is modulated by IL‐1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding
2017 StandoutNobel
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
2020 Standout
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
2020 Standout
Works of James D. Chalmers being referenced
2016
Epidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care-Associated Pneumonia: A UK Cohort Study
2011
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease
2017
Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia
2016
Predictors of Mortality in Hospitalized Adults with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis
2013
A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis
2015
Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic
2010
Vascular complications are associated with poor outcome in community-acquired pneumonia
2011
Burden and risk factors forPseudomonas aeruginosacommunity-acquired pneumonia: a multinational point prevalence study of hospitalised patients
2018
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study
2016
Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial
2014
Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis
2010
Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
2011
Severity assessment in community-acquired pneumonia: a review
2009
Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?
2014
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective: Table 1
2013
Are biomarkers additive to pulmonary embolism severity index for severity assessment in normotensive patients with acute pulmonary embolism?
2010
Role of cephalosporins in the era ofClostridium difficileinfection
2016
Right ventricular dilation on CT pulmonary angiogram independently predicts mortality in pulmonary embolism
2010
Inhaled corticosteroids and risk of pneumonia: evidence for and against the proposed association
2010
Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis
2010
Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis
2013
Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia
2008
A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis
2010
Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies
2013
Statins in community acquired pneumonia: Evidence from experimental and clinical studies
2010
Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit
2015
Incidence and Prognostic Implications of Acute Kidney Injury on Admission in Patients With Community-Acquired Pneumonia
2010
Cardiovascular disease as a complication of community-acquired pneumonia
2016
Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis
2011
Management of bronchiectasis in adults
2015
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis
2011
Validation of the Infectious Diseases Society of America/American Thoratic Society Minor Criteria for Intensive Care Unit Admission in Community-Acquired Pneumonia Patients Without Major Criteria or Contraindications to Intensive Care Unit Care
2011
The role of neutrophils in cystic fibrosis
2013
Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia
2009
C-Reactive Protein Is an Independent Predictor of Severity in Community-acquired Pneumonia
2008
Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis
2012
Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization
2016
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis
2017
The Bronchiectasis Severity Index. An International Derivation and Validation Study
2014
Prior Statin Use Is Associated with Improved Outcomes in Community-acquired Pneumonia
2008
An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia
2013
Clinical Tuberculosis
2015
Secreted mucins and airway bacterial colonization in non‐CF bronchiectasis
2015
Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis.
1981